Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

James Williams, H.; F. Willkens, Robert; O. Samuelson, Cecil; S. Alarcón, Graciela; Guttadauria, Maria; Yarboro, Cheryl; P. Polisson, Richard; R. Weiner, Steven; E. Luggen, Michael; M. Billingsley, Lynn; L. Dahl, Stephen; J. Egger, Marlene; C. Reading, James; Ward, John

doi:10.1002/art.1780280702

Public

Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

Published in Arthritis & Rheumatism • Jul 1, 1985

Authors:

H. James Williams

Robert F. Willkens

Cecil O. Samuelson

Abstract

One hundred eighty-nine patients with rheumatoid arthritis were entered into a prospective, controlled, double-blind multicenter trial comparing placebo and methotrexate (MTX). One hundred ten patients completed 18 weeks of therapy. No remissions were seen, but patients able to tolerate low-dose pul...

Subject

Medicine

Rheumatoid arthritis

Methotrexate

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!